Dr. Vahdat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
34 Maple St
Whittingham cancer center
Norwalk, CT 06850Phone+1 203-845-4811- Is this information wrong?
Education & Training
Massachusetts Institute of Technology, Sloan School of ManagementMBA, Business, 2012 - 2014
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1991 - 1994
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1987 - 1990- Icahn School of Medicine at Mount SinaiClass of 1987
Certifications & Licensure
NY State Medical License 1988 - 2025
NH State Medical License 2022 - 2024
VT State Medical License 2023 - 2024
CT State Medical License 2017 - 2022- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Response to Kochan et al., 2023.Barbara E Ehrlich, Linda Vahdat, Arthur P DeCillis, Andrew Seidman> ;Supportive Care in Cancer. 2023 Jul 22
- 2 citationsCopper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-β signaling pathways in cancer.Ensieh M Poursani, Daniele Mercatelli, Prahlad Raninga, Jessica L Bell, Federica Saletta, Felix V Kohane, Daniel P Neumann, Ye Zheng, Jourdin R C Rouaen, Toni Rose Jue...> ;Cell & Bioscience. 2023 Jul 21
- 24 citationsLow lamin A levels enhance confined cell migration and metastatic capacity in breast cancer.Emily S Bell, Pragya Shah, Noam Zuela-Sopilniak, Dongsung Kim, Alice-Anais Varlet, Julien L P Morival, Alexandra L McGregor, Philipp Isermann, Patricia M Davidson, Jos...> ;Oncogene. 2022 Sep 1
- Join now to see all
Press Mentions
Post-ASCO News Alert: AstraZeneca’s/Merck’s Lynparza Use in Niche HR+ gBRCA-Mutant Breast Cancer Subgroup Could Compete with VerzenioJune 21st, 2021- HistoIndex Explores the Clinical Utility of Stain-Free AI Digital Pathology Platform in 388 Patients with Triple-Negative Breast Cancer (TNBC)January 25th, 2021
- Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast CancerJanuary 22nd, 2021
- Join now to see all
Hospital Affiliations
Memorial Sloan Kettering Cancer CenterNew York, New York- Norwalk HospitalNorwalk, Connecticut
Dartmouth-Hitchcock Medical CenterLebanon, New Hampshire
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
